BTX

BioTime CEO Dr. Michael West to Present at 9th Annual Stem Cell Summit

[Business Wire] – BioTime, Inc. , a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. moreView todays social media effects on BTXView the latest stocks trending across Twitter. Click to view dashboardSee who BioTime is hiring next, click here to view […]

WPCS International Incorporated (WPCS) news: Trade WPCS …

(Editors’ Note: This article covers a stock trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.)Nearly everyone has heard about it, but not many really know what it is. I’m talking about the mysterious digital currency known as Bitcoin. I have always been […]

LifeMap Sciences, a Subsidiary of BioTime, Announces Release of LifeMap Discoveryâ„¢ Version 1.1 with Enhanced Therapeutic Discovery and Commercial Utility

[at noodls] – ALAMEDA, Calif., March 25, 2013 – LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of LifeMap Discoveryâ„¢ version 1.1 (discovery.lifemapsc.com). LifeMap … moreView todays social media effects on BTXView the latest stocks trending across Twitter. Click to view dashboardSee who BioTime is hiring next, click here to view […]

Geron to Divest Stem Cell Assets

[at noodls] – MENLO PARK, Calif., January 7, 2013 — Geron Corporation (Nasdaq: GERN) today announced that on January 4, 2013, it entered into an Asset Contribution Agreement (the Agreement) with BioTime, … moreView todays social media effects on BTXView the latest stocks trending across Twitter. Click to view dashboardSee who BioTime is hiring next, click here to view […]

Geron Announces Non-Binding Letter of Intent with BioTime Regarding Stem Cell Assets

[at noodls] – MENLO PARK, Calif., November 15, 2012 — Geron Corporation (Nasdaq: GERN) today announced that the company has entered into a non-binding letter of intent (LOI) with BioTime, Inc. (NYSE: BTX) and BioTime’s … moreView todays social media effects on BTXView the latest stocks trending across Twitter. Click to view dashboard […]

PropThink: Geron Q3 Earnings Review: Waiting Not for Godot, but for San Antonio and Atlanta

[ACN Newswire] – By Ivan DeryuginWhen a biotechnology company is around 20 years after its incorporation, common wisdom would suggest that it has become a major player in the biotechnology sector, with at least one blockbuster … moreView todays social media effects on BTXView the latest stocks trending across Twitter. Click to view dashboard […]

Geron Acknowledges Letter to its Stockholders from BioTime

[at noodls] – MENLO PARK, Calif., October 19, 2012 — Geron Corporation (Nasdaq: GERN) today acknowledged the public release by BioTime, Inc. (NYSE: BTX) of a letter to Geron’s stockholders regarding Geron’s stem cell … moreView todays social media effects on BTXView the latest stocks trending across Twitter. Click to view dashboard […]

PropThink: Stem Cell Divestiture May Benefit Geron Shareholders More than the Company

[ACN Newswire] – By Jake KingGeron Corp (NASDAQ:GERN) may have finally found a buyer for its suspended stem cell program. The company has been searching since November of 2011 when Geron halted the projects to focus on … moreView todays social media effects on BTXView the latest stocks trending across Twitter. Click to view dashboard […]